Grail (NASDAQ:GRAL) Stock Price Down 6.6% – Time to Sell?

Grail, Inc. (NASDAQ:GRAL)’s stock price fell 6.6% during mid-day trading on Monday . The stock traded as low as $27.66 and last traded at $28.28. 214,893 shares traded hands during trading, a decline of 80% from the average session volume of 1,050,701 shares. The stock had previously closed at $30.28.

Analyst Upgrades and Downgrades

Several research firms have recently commented on GRAL. Morgan Stanley assumed coverage on Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective on the stock. Guggenheim assumed coverage on shares of Grail in a research report on Thursday, October 17th. They issued a “neutral” rating for the company. Finally, Wolfe Research started coverage on shares of Grail in a research note on Friday, November 15th. They issued a “peer perform” rating for the company.

Grail Price Performance

The firm’s fifty day moving average price is $20.34 and its 200 day moving average price is $16.64.

Grail (NASDAQ:GRAL) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($3.94) EPS for the quarter. The business had revenue of $28.65 million for the quarter. As a group, research analysts expect that Grail, Inc. will post -65.16 EPS for the current fiscal year.

Insider Activity at Grail

In other Grail news, CFO Aaron Freidin sold 30,452 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now directly owns 268,277 shares in the company, valued at $3,761,243.54. This represents a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

Institutional Trading of Grail

Several hedge funds and other institutional investors have recently bought and sold shares of GRAL. Wesbanco Bank Inc. bought a new position in shares of Grail during the fourth quarter valued at approximately $523,000. Slow Capital Inc. purchased a new position in Grail during the 4th quarter valued at $2,379,000. Perigon Wealth Management LLC bought a new position in Grail in the 4th quarter valued at $260,000. 180 Wealth Advisors LLC purchased a new stake in Grail in the fourth quarter worth $1,681,000. Finally, Douglas Lane & Associates LLC bought a new stake in shares of Grail during the fourth quarter worth $3,034,000.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.